Latest BioPharma News and In-Depth Analysis

Ordinary and Extraordinary General Meeting of April 12, 2023

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, will hold its Or...

March 26, 2023 | Sunday | News

Abcam's Rich Lane Talks Expansion in APAC Region

What are the major plans in store for the new APAC hub at Singapore? For a company like Abcam which strongly believes that collaboration is a big driver o...

March 26, 2023 | Sunday | Influencers

Enhanced traceability plays a crucial role in building a resilient biopharma supply chain

How do you foresee digitalisation trends in APAC pharmaceutical supply chain improvising visibility, agility, and business resilience? Unpredict...

March 26, 2023 | Sunday | Influencers

ProfoundBio showcases PRO1184's antitumor activity at AACR 2023

ProfoundBio, a clinical stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential, will present t...

March 26, 2023 | Sunday | News

Partner Content

BioPharma BreakThrough's

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

March 26, 2023 | Sunday | News

March 26, 2023 | Sunday | Influencers

March 26, 2023 | Sunday | Influencers

March 26, 2023 | Sunday | News